add directory ♦ physician opportunity
Today's News:
Pharma Industry / Biotech Industry News From Medical News Today
Amgen And Wyeth Statement On The FDA Safety Announcement Regarding Tumor Necrosis Factor (TNF) Blockers
Sat, 06 Sep 2008 08:00:00 -0700
Amgen (NASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), issued a statement in response to the Food and Drug Administration (FDA) safety announcement regarding opportunistic fungal infections in patients treated with Tumor Necrosis Factor (TNF) blockers [marketed as Remicade® (infliximab), Enbrel® (etanercept), Humira® (adalimumab) and Cimzia® (certolizumab pegol)].
USP's 2008 Annual Scientific Meeting To Convene Scientific Experts From Around The World
Sat, 06 Sep 2008 05:00:00 -0700
The U.S. Pharmacopeial (USP) Convention's 2008 Annual Scientific Meeting (ASM) will be held in Kansas City, Mo., September 24 to 26. The meeting is an opportunity to interact with the USP experts responsible for establishing internationally recognized standards for prescription and over-the-counter medicines, food ingredients and dietary supplements. The focus will be on Quality of Manufactured Medicines, Food Ingredients and Dietary Supplements.
An Essential And Comprehensive Report On Biopharmaceuticals In The US And European Markets, By Research And Markets
Sat, 06 Sep 2008 03:00:00 -0700
Research and Markets has announced the addition of the "Biopharmaceuticals in the US and European Markets" report to their offering.
Pharmacy / Pharmacist News From Medical News Today
Pharmacy White Paper Consultation On Legislative Changes
Sat, 06 Sep 2008 09:00:00 -0700
In response to the Pharmacy White Paper related consultation on legislative changes published on 27 August, the NPA has called for new money to be made available for future pharmacy services and for a clear timetable to be put in place for a more ordered entry of businesses into the pharmacy market. John Turk, NPA Chief Executive said: "The consultation heralds further reforms of entry into the pharmacy market.
Handling, Transfer And Transport Of Waste Consultation - Pharmacy Bodies Comment
Sat, 06 Sep 2008 07:00:00 -0700
The NPA is one of five bodies representing community pharmacy businesses that have submitted a joint response to the second consultation carried out by DEFRA on the Handling, Transfer and Transport of Waste. The consultation seeks views on the measures needed to reduce the incidence of fly-tipping and inappropriate disposal of waste.
USP's 2008 Annual Scientific Meeting To Convene Scientific Experts From Around The World
Sat, 06 Sep 2008 05:00:00 -0700
The U.S. Pharmacopeial (USP) Convention's 2008 Annual Scientific Meeting (ASM) will be held in Kansas City, Mo., September 24 to 26. The meeting is an opportunity to interact with the USP experts responsible for establishing internationally recognized standards for prescription and over-the-counter medicines, food ingredients and dietary supplements. The focus will be on Quality of Manufactured Medicines, Food Ingredients and Dietary Supplements.
Food and Drug Administration Press Releases
FDA to Post Quarterly Report of Potential Safety Issues
Fri, 05 Sep 2008 15:57:00 -0000
The U.S. Food and Drug Administration announced today that it has posted on its Web site its first quarterly report that lists certain drugs that are being evaluated for potential safety issues. The drugs have been identified based on a review of reports in FDA's Adverse Event Reporting System (AERS).
FDA Approves DNA Test to Measure Hepatitis B Virus Levels
Thu, 04 Sep 2008 18:12:00 -0000
The U.S. Food and Drug Administration today approved the first nucleic acid test for hepatitis B virus (HBV) that measures the amount of viral DNA (viral load) in a patient's blood. Assessing a patient's viral load provides health care professionals with a highly sensitive method for gauging the progress of antiviral therapy in patients with chronic HBV infections.
FDA: Manufacturers of TNF-Blocker Drugs Must Highlight Risk of Fungal Infections
Thu, 04 Sep 2008 15:14:00 -0000
The U.S. Food and Drug Administration today announced that the manufacturers of Humira, Cimzia, Enbrel, and Remicade must strengthen the existing warnings, in the Warnings and Precaution sections of the drugs' prescribing information and Medication Guides, on the risk of developing opportunistic fungal infections. Some patients with invasive fungal infections have died.
Food and Drug Administration--Recalls
Recall of Patak's Dopiaza Cooking Sauce (September 4)
Fri, 05 Sep 2008 22:00:00 -0000
ACH Food Companies, Inc. is recalling its Patak's Dopiaza Cooking Sauce sold in the United States because it may contain an undeclared milk allergen. People who have an allergy or severe sensitivity to milk may run the risk of serious or life-threatening allergic reaction if they consume these products. The product is distributed nationally through retail stores. ACH Food Companies is notifying its distributors and stores that carry this product that it contains an undeclared milk allergen and to immediately remove it from distribution.
Sprouters Northwest, Inc. Recalls Alfalfa Sprout Products Because of Possible Health Concern (September 5)
Fri, 05 Sep 2008 18:58:00 -0000
Sprouters Northwest, Inc. of Kent, Washington is recalling its alfalfa sprout products (alfalfa sprouts, onion sprouts, and salad sprouts) because they may be linked to a recent outbreak of Salmonellosis in Oregon and Washington State. To date, 13 cases of Salmonella Typhimirium infection have been associated with the consumption of raw alfalfa sprouts.
T. Marzetti Company Recalls a Limited Number of Girard's Honey Dijon Peppercorn (September 4)
Fri, 05 Sep 2008 18:33:00 -0000
T. Marzetti Company is recalling a limited number of 12 fl. oz. bottles of Girard's Honey Dijon Peppercorn (item 58105) because they may have the incorrect back label of Girard's French Dressing (item 58015). The Girard's Honey Dijon Peppercorn contains eggs, which is not declared as an ingredient on the Girard's French label. People who have allergies to egg run the risk of serious allergic reaction if they consume this product.
Subscribe to Nuclear_Pharmacy RSS feed 
Amgen And Wyeth Statement On The FDA Safety Announcement Regarding Tumor Necrosis Factor (TNF) Blockers
Sat, 06 Sep 2008 08:00:00 -0700
Amgen (NASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), issued a statement in response to the Food and Drug Administration (FDA) safety announcement regarding opportunistic fungal infections in patients treated with Tumor Necrosis Factor (TNF) blockers [marketed as Remicade® (infliximab), Enbrel® (etanercept), Humira® (adalimumab) and Cimzia® (certolizumab pegol)].
USP's 2008 Annual Scientific Meeting To Convene Scientific Experts From Around The World
Sat, 06 Sep 2008 05:00:00 -0700
The U.S. Pharmacopeial (USP) Convention's 2008 Annual Scientific Meeting (ASM) will be held in Kansas City, Mo., September 24 to 26. The meeting is an opportunity to interact with the USP experts responsible for establishing internationally recognized standards for prescription and over-the-counter medicines, food ingredients and dietary supplements. The focus will be on Quality of Manufactured Medicines, Food Ingredients and Dietary Supplements.
An Essential And Comprehensive Report On Biopharmaceuticals In The US And European Markets, By Research And Markets
Sat, 06 Sep 2008 03:00:00 -0700
Research and Markets has announced the addition of the "Biopharmaceuticals in the US and European Markets" report to their offering.
Pharmacy / Pharmacist News From Medical News Today
Pharmacy White Paper Consultation On Legislative Changes
Sat, 06 Sep 2008 09:00:00 -0700
In response to the Pharmacy White Paper related consultation on legislative changes published on 27 August, the NPA has called for new money to be made available for future pharmacy services and for a clear timetable to be put in place for a more ordered entry of businesses into the pharmacy market. John Turk, NPA Chief Executive said: "The consultation heralds further reforms of entry into the pharmacy market.
Handling, Transfer And Transport Of Waste Consultation - Pharmacy Bodies Comment
Sat, 06 Sep 2008 07:00:00 -0700
The NPA is one of five bodies representing community pharmacy businesses that have submitted a joint response to the second consultation carried out by DEFRA on the Handling, Transfer and Transport of Waste. The consultation seeks views on the measures needed to reduce the incidence of fly-tipping and inappropriate disposal of waste.
USP's 2008 Annual Scientific Meeting To Convene Scientific Experts From Around The World
Sat, 06 Sep 2008 05:00:00 -0700
The U.S. Pharmacopeial (USP) Convention's 2008 Annual Scientific Meeting (ASM) will be held in Kansas City, Mo., September 24 to 26. The meeting is an opportunity to interact with the USP experts responsible for establishing internationally recognized standards for prescription and over-the-counter medicines, food ingredients and dietary supplements. The focus will be on Quality of Manufactured Medicines, Food Ingredients and Dietary Supplements.
Food and Drug Administration Press Releases
FDA to Post Quarterly Report of Potential Safety Issues
Fri, 05 Sep 2008 15:57:00 -0000
The U.S. Food and Drug Administration announced today that it has posted on its Web site its first quarterly report that lists certain drugs that are being evaluated for potential safety issues. The drugs have been identified based on a review of reports in FDA's Adverse Event Reporting System (AERS).
FDA Approves DNA Test to Measure Hepatitis B Virus Levels
Thu, 04 Sep 2008 18:12:00 -0000
The U.S. Food and Drug Administration today approved the first nucleic acid test for hepatitis B virus (HBV) that measures the amount of viral DNA (viral load) in a patient's blood. Assessing a patient's viral load provides health care professionals with a highly sensitive method for gauging the progress of antiviral therapy in patients with chronic HBV infections.
FDA: Manufacturers of TNF-Blocker Drugs Must Highlight Risk of Fungal Infections
Thu, 04 Sep 2008 15:14:00 -0000
The U.S. Food and Drug Administration today announced that the manufacturers of Humira, Cimzia, Enbrel, and Remicade must strengthen the existing warnings, in the Warnings and Precaution sections of the drugs' prescribing information and Medication Guides, on the risk of developing opportunistic fungal infections. Some patients with invasive fungal infections have died.
Food and Drug Administration--Recalls
Recall of Patak's Dopiaza Cooking Sauce (September 4)
Fri, 05 Sep 2008 22:00:00 -0000
ACH Food Companies, Inc. is recalling its Patak's Dopiaza Cooking Sauce sold in the United States because it may contain an undeclared milk allergen. People who have an allergy or severe sensitivity to milk may run the risk of serious or life-threatening allergic reaction if they consume these products. The product is distributed nationally through retail stores. ACH Food Companies is notifying its distributors and stores that carry this product that it contains an undeclared milk allergen and to immediately remove it from distribution.
Sprouters Northwest, Inc. Recalls Alfalfa Sprout Products Because of Possible Health Concern (September 5)
Fri, 05 Sep 2008 18:58:00 -0000
Sprouters Northwest, Inc. of Kent, Washington is recalling its alfalfa sprout products (alfalfa sprouts, onion sprouts, and salad sprouts) because they may be linked to a recent outbreak of Salmonellosis in Oregon and Washington State. To date, 13 cases of Salmonella Typhimirium infection have been associated with the consumption of raw alfalfa sprouts.
T. Marzetti Company Recalls a Limited Number of Girard's Honey Dijon Peppercorn (September 4)
Fri, 05 Sep 2008 18:33:00 -0000
T. Marzetti Company is recalling a limited number of 12 fl. oz. bottles of Girard's Honey Dijon Peppercorn (item 58105) because they may have the incorrect back label of Girard's French Dressing (item 58015). The Girard's Honey Dijon Peppercorn contains eggs, which is not declared as an ingredient on the Girard's French label. People who have allergies to egg run the risk of serious allergic reaction if they consume this product.
Sites:
Amersham PLC: Provides pharmaceutical products for the diagnosis and treatment of disease and technologies for biotechnology research and drug discovery. Site contains history, investor information, press releases, and describes the services offered.Cardiolite: A product created by DuPont which is used to evaluate coronary blood flow. Site contains case studies, a bibliography, upcoming events, prescription information, a mailing list, and educational seminars.
CORPIUS: Reference manual contains all of the currently available radiopharmaceutical package inserts within the United States.
International Commission on Radiological Protection: Provides recommendations and guidance on all aspects of protection against ionising radiation. Contains press releases, draft reports, publications, and a listing of activities.
International Society of Radiolabeled Blood Elements: Their history and statute, as well as a newsletter and congress information. Paid membership provides access to their paper bank and associate list.
Mallinckrodt Imaging: Tyco Healthcare/Mallinckrodt is not only a major worldwide manufacturer of nuclear medicine products with its facilities in St. Louis, MO and the Netherlands; it is a major network of Radiopharmacies.
Mid-Atlantic Nuclear Training Group: A forum for 10 member utilities within US Nuclear Regulatory Commission Region I to discuss issues pertaining to nuclear training and the nuclear industry. Site contains related links, committees information, a training topic bulletin board, and an instructor workshop.
Nuclear Pharmacy Online Education: An educational program geared towards students and pharmacists interested in nuclear pharmacy. Site contains history, a listing of goals, registration details, faculty, courses, and requirements. Sponsored by the University of New Mexico and University of Arkansas.
NuclideNavigator Lite: A program to view, query, and extract gamma-ray, alpha-particle, and beta-particle energies and yields, half-lives, parent/daughter relations, and neutron absorptions from the TORI library.
P.E.T. Net Pharmaceuticals, Inc.: Owns and operates the Positron Radiopharmacy Network of manufacturing and distribution centers where PET radiopharmaceuticals are produced and distributed to nearby hospitals and clinics. Contains a corporate overview, radiation safety, licensing requirements, press releases, and a list of indica...
Purdue University: Division of Nuclear Pharmacy: Offers professional and post-graduate training opportunities for students and pharmacists interested in the practice of nuclear pharmacy.
Radiopharmacy Management System: A software system for the overseeing of customers, hot labs, and the department of a radiopharmacy's business. Contains a listing of features, downloads, FAQs, and documentation. Provided by Pinestar Technology, Inc. based in Greenville, Pennsylvania, United States.
Radiopharmacy, Inc.: Registered pharmacy specializing in the preparation and delivery of radioactive drugs in Evansville, Indiana, United States. Contains a listing of services, staff listing, products provided, news items, and related links.
Radpharm Scientific Pty. Ltd.: Provides radiopharmaceuticals to medical practices in Australia and export to New Zealand, Singapore, Malaysia, Thailand and Hong Kong. Includes a listing of services, various decay charts, press releases, and employment opportunities. Located in Belconnen, Australian Capital Territory.
RXInsder: Nuclear Pharmacy Jobs: Nuclear pharmacy jobs & pharmacist employment opportunities in nuclear pharmacy
Scintimammography: Describes the use of a radioactive tracer to identify abnormal cells based on the difference in metabolic characteristics between cancerous and non-cancerous cells. Site contains pictures, FAQs, history, and a description of the process. Sponsored by the Harbor-UCLA Medical Center.
The Nuclear Pharmacy: Describes training requirements, training information, news, and educational materials for current and prospective nuclear pharmacists. Site provides job postings, product recalls, related links, and a list of drug interactions.
UCLA Department of Molecular and Medical Pharmacology: This site offers general information about the faculty and the graduate program. Information about positron emission tomography (PET), among other online resources can also be found.
UK Radiopharmacy Group: UKRG
Welcome to the Strange World of Radiopharmacy: An introduction to the specialty with a listing of tracers, European institutes, publications, and contacts.
World Nuclear Transport Institute: Presents international, consolidated industry views on radioactive materials transport. Provides membership details, a staff listing, related links, upcoming events, and information sheets.
This directory is based on the Open Directory and may have been modified